Costly drugs | February 27, 2017 Issue – Vol. 95 Issue 9 | Chemical & Engineering News

March 25, 2017

Pushback on costly #drugs
http://CEN.acs.org/articles/95/i9/Pushback.html Table of signpost meds: $80k Sovaldi hep. C treatment, $14k/yr for PCSK9 inhibitor Repatha

This entry was posted on March 25, 2017 at 7:53 pm and is filed under -.

Tags: , ,